Dergiler / Respiratory Case Reports / 2018 / Cilt: 7 - Sayı: 2

A Case of Sjögren’s Syndrome-Related Pulmonary Arterial Hypertension Treated with Iloprost and Bosentan Combination Therapy

İloprost ve Bosentan Kombinasyon Tedavisi Uygulanan Bir Sjögren Sendromu İlişkili Pulmoner Hipertansiyon Olgusu

Sayfa
59–62
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The aim of this manuscript was to present a case of SS-related PAH (SRP) followed under bosentan and iloprost combination therapy.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Sjögren’s syndrome (SS), which is characterized by lymphocytic infiltration of the exocrine glands, is the second most common multisystem autoimmune disease after rheumatoid arthritis.
📊
Temel Bulgular & Veri:Pulmonary involvement ranges from 9% to 20% and it usually occurs as an airway disease or interstitial lung disease.
💡
Sonuç & Katkı:The aim of this manuscript was to present a case of SS-related PAH (SRP) followed under bosentan and iloprost combination therapy.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Sjögren’s syndrome (SS), which is characterized by lymphocytic infiltration of the exocrine glands, is the second most common multisystem autoimmune disease after rheumatoid arthritis. Pulmonary involvement ranges from 9% to 20% and it usually occurs as an airway disease or interstitial lung disease. Pulmonary arterial hypertension (PAH) is a very rare condition in SS. In SS-associated PAH, the functional class of patients is usually World Health Organization (WHO) Class III/IV and there is no specific treatment regimen. In addition to nonspecific medical treatment for PAH, treatment of the underlying disease and supportive therapy are important. The aim of this manuscript was to present a case of SS-related PAH (SRP) followed under bosentan and iloprost combination therapy.

Abstract

Sjögren Sendromu (SS) ekzokrin glandların lenfositik infiltrasyonu ile karakterize, romatoid artritten sonra ikinci en sık görülen multisitem otoimmün hastalıktır. Pulmoner tutulum %9-20 sıklıkta bildirilmiştir ve genellikle hava yolu hastalığı ya da interstisyel akciğer hastalığı şeklinde görülür. Pulmoner Arteriyel Hipertansiyon (PAH) gelişimi SS’da çok nadir bir durumdur. SS ilişkili PAH’da hastalar genellikle fonksiyonel sınıf WHO-III/IV’dür ve spesifik bir tedavi rejimi yoktur. PAH’ın nonspesifik tedavisine ek olarak altta yatan hastalığın tedavisi önemlidir. Bu yazıdaki amacımız iloprost ve bosentan kombinasyon tedavisi altında izlediğimiz bir SS ilişkili PAH (SİP) olgusunu takdim etmektir.

🔖

Bu Makaleye Atıf Yap

BAHA, A., EKİCİ, B., OGAN, N., AKPINAR, E. E. (2018). A Case of Sjögren’s Syndrome-Related Pulmonary Arterial Hypertension Treated with Iloprost and Bosentan Combination Therapy. Respiratory Case Reports, Cilt: 7 - Sayı: 2, 59–62. https://ajindex.com/articles/302539

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Flament T, Bigot A, Chaigne B, Henique H, Diot E, Marchand-Adam S. Pulmonary manifestations of Sjögren’s Syndrome. Eur Respir Rev 2016; 25:110–23. [CrossRef] 2. Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M. Pulmonary arterial hypertension: a rare complication of primary Sjogren Syndrome report of 9 new cases and review of the literature. Medicine (Baltimore) 2007; 86:299-315. 3. Fujita T1, Tanabe N, Kasahara Y, Sugiura T, Sakao S, Tatsumi K. Withdrawal of epoprostenol therapy in a patient with pulmonary hypertension associated with Sjögren’s syndrome. Intern Med 2014; 53:2237-40 4. Guerreso K, Conner EA. Possible role of anti-SSA/Ro antibodies in the pathogenesis of pulmonary hypertension. Respir Med Case Rep 2016; 17:47-9. [CrossRef] 5. Zhao J, Wang Q, Liu Y, Tian Z, Guo X, Wang H, et al. Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: A cohort study in China. Int J Cardiol 2017; 236:432–7. [CrossRef] 6. Hwang JA, Yang TH, Lee JY, Koo DW, Choi IS, Cho SY, et al. Severe pulmonary hypertension in primary Sjögren’s syndrome. Korean Circ J 2013; 43:504-7. [CrossRef] 7. YJ Hao, X Jiang, W Zhou, Wang Y, Gao L, Wang Y et al. Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients. Eur Respir J 2014; 44:963–72. [CrossRef] 8. Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009; 179:151 -7. [CrossRef] 9. Kokosi M, Riemer EC, Highland KB. Pulmonary involvement in Sjögren syndrome. Clin Chest Med 2010; 31:489-500. [CrossRef]